Predictive Oncology’s Breakthrough in Drug Repurposing Offers Hope for Patients
/0 Comments/in Drug repurposing, Preclinical Research/by MaxPhase 1 Soon Recruiting: MK-2400 (Ifinatamab Deruxtecan) for Metastatic Prostate Cancer
/0 Comments/in Clinical Trial, Metastatic, Phase 1/by MaxNewsletter 15/2025
/0 Comments/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hi fellow warriors! This week brings a solid batch of seven articles. From bold new strategies to cutting-edge trials, it seems that momentum is building. Stay strong and fight on! As usual, we also have a podcast if you prefer to listen […]
Phase 1 Trial: The COSMYC Trial, ZEN-3694 Combination With BAT
/0 Comments/in Clinical Trial, Metastatic, Phase 2/by MaxPhase 2 Trial Enrolling: Combination Therapy for Metastatic Castration-Resistant Prostate Cancer
/0 Comments/in Clinical Trial, Metastatic, Phase 2/by MaxPhase 1 Enrolling: Sylvester Cancer Center Launches Innovative Clinical Trial for High-Grade Neuroendocrine Tumors
/0 Comments/in Clinical Trial, Metastatic, Phase 1/by MaxAdvancements in Delivery: Gene Therapy Could Help Prostate Cancer Treatment
/0 Comments/in CRISPR, Delivery, Preclinical Research/by MaxUpdate: FC705 Signals a Leap Forward in Prostate Cancer Therapy, Outperforming Pluvicto
/0 Comments/in Clinical Trial, Metastatic, Phase 2/by MaxNew Molecule Boosts Vaccine Power Against Cancer and Viruses, In Vivo Study
/0 Comments/in Immunotherapy, Preclinical Research/by MaxProject Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
225Ac abiraterone acetate ADC AI ai in healthcare alphafold antibody-drug conjugate apalutamide ATM bispecific antibody bone metastases bone metastasis BRCA BRCA2 cancer immunotherapy CAR-T clinical trial clinical trials crispr CYP11A1 inhibitor darolutamide drug repurposing drug resistance enzalutamide HRR immunotherapy mcrpc metastatic castration-resistant prostate cancer metastatic hormone-sensitive prostate cancer mHSPC mRNA MYC NEPC neuroendocrine prostate cancer olaparib oncolytic virus personalized medicine Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data theranostics
Latest Posts
- OMNIRAY: a Phase 1 Clinical Trial for LY4257496 for mCRPC August 20, 2025
- Nutrition and Inflamation: New Research Unveils Five Universal Patient Clusters in Oncology August 19, 2025
- Nuanced Benefits of Fasting-Mimicking Diets: High Protein vs. Low Protein August 18, 2025
- Newsletter 33/2025 August 17, 2025